{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hypercholesterolemia-due-to-cholesterol-7alpha-hydroxylase-deficiency","columns":[{"gene":"","key":"population-e04b99cb3222cd5dabbc","label":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","mondoId":"MONDO:0016203","onsetQualifier":null,"originColumnKey":"MONDO:0016203/ORPHA:209902","originalViews":[{"key":"MONDO:0016203/ORPHA:209902","label":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","scopeLabel":"ORPHA:209902","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["176bf8185578ee1196d38c268a6dce62281a14a99c83a8843d32896494c49f75","1d56eba9775f050a606d03b6cb3709a8a86adc432542f5218484edc9e3b5136c","36c22188e791719c80421b7d9c8db2fa80f8973bc925adf5e95341165c47fd70","3a5a3dc4d18898cc494673080e78a1130551e75908a397c8a6497a646473a58a","40c0db33c3dd87398f8da8dde9db63abf0088855cc3ee917afb6c675adcf83c5","53a3fe6e84c5fc415606abc4c71e7cb6236b2026fa4fdd58328c7b52c50a0c30","543ced4a37e1225c141d9b3715f4223dbe4e8b438df2e75fd609de8f284315bf","a7dfb37196efede66dcb87d89925c0127664e3046cf9603f229fe8b512ddeb5c","a903d9b5336f90504f088eaa099b022bc84fe683b3c0fe103aa6a80950e4fae8","ab6c9e0be4609be55a122d277733ad78d9bb485fe8b692d25a3f5a2086c7ba59","ac88f4d9a49f356a689c9f54ac9918a426831d4b70db4c37a39375f428fc73d2","c6130016cdcb7a8b235cdb83222ebbf0c0cb00c9a100a8333ffeb417553fe309","dffd2d5abe8e79245b3ec5967eb584467f422dab88caa9992d7bbd60691b75cb","f316e4f3c7f450d5aa993391ac61509f55952018ab8488a82b392a6de743b04a","f404ca633a8e7ef47a0c98fba57d263d53ec26bca73df9a1556faf225ec71f87"],"recordQualifiers":{},"scopeLabel":"ORPHA:209902","sourceIds":["ORPHA:209902"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e04b99cb3222cd5dabbc"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0008372","HP:0100514","HP:0004943","HP:0006573","HP:0012397","HP:0001396","HP:0011980"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"orphanet":15}},"features":[{"hpoId":"HP:0008372","label":"Abnormal circulating vitamin A concentration","primary":true},{"hpoId":"HP:0100514","label":"Abnormal circulating vitamin E concentration","primary":true},{"hpoId":"HP:0004943","label":"Accelerated atherosclerosis","primary":true},{"hpoId":"HP:0006573","label":"Acute hepatic steatosis","primary":true},{"hpoId":"HP:0012397","label":"Aortic atherosclerotic lesion","primary":true},{"hpoId":"HP:0001396","label":"Cholestasis","primary":true},{"hpoId":"HP:0011980","label":"Cholesterol gallstones","primary":true},{"hpoId":"HP:0001677","label":"Coronary artery atherosclerosis","primary":false},{"hpoId":"HP:0003141","label":"Elevated circulating LDL-C concentration","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0012115","label":"Hepatitis","primary":false},{"hpoId":"HP:0003124","label":"Hypercholesterolemia","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0001403","label":"Macrovesicular hepatic steatosis","primary":false},{"hpoId":"HP:0001513","label":"Obesity","primary":false}],"ledeHtml":"A rare sterol metabolism disorder characterized by increased LDL cholesterol serum levels (which are resistant to treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors), hypertriglyceridemia, and decreased rate of bile acid excretion, resulting from cholesterol 7alpha-hydroxylase deficiency. Premature gallstone disease and/or premature coronary and peripheral vascular disease are frequently associated.","mondoId":"MONDO:0016203","node":{"canonicalSlug":"hypercholesterolemia-due-to-cholesterol-7alpha-hydroxylase-deficiency","comparisons":[{"documentSha256":"cad0d5f7e5cd1e970d307712034e26a901b23710c935e5a7f5a2be108d2beaa6","key":"legacy-hypercholesterolemia-due-to-cholesterol-7alpha-hydroxylase-deficiency","kind":"legacy","label":"hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","memberIds":["MONDO:0016203"],"mondoId":"MONDO:0016203","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hypercholesterolemia-due-to-cholesterol-7alpha-hydroxylase-deficiency.cad0d5f7e5cd1e970d307712034e26a901b23710c935e5a7f5a2be108d2beaa6.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","originalSourceId":"ORPHA:209902","paragraphs":["A rare sterol metabolism disorder characterized by increased LDL cholesterol serum levels (which are resistant to treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors), hypertriglyceridemia, and decreased rate of bile acid excretion, resulting from cholesterol 7alpha-hydroxylase deficiency. Premature gallstone disease and/or premature coronary and peripheral vascular disease are frequently associated."],"rawAttribution":"ORPHA:209902","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:34Z","upstream":"ORPHA:209902","url":"https://rarediseases.info.nih.gov/diseases/20441"},"ownColumnKeys":["population-e04b99cb3222cd5dabbc"],"publication":"published","relationships":[{"kind":"parent","label":"familial hypercholesterolemia","mondoId":"MONDO:0005439","slug":null},{"kind":"parent","label":"inborn disorder of bile acid synthesis","mondoId":"MONDO:0019218","slug":"inborn-disorder-of-bile-acid-synthesis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"176bf8185578ee1196d38c268a6dce62281a14a99c83a8843d32896494c49f75","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003124","is_excluded":false,"label":"Hypercholesterolemia","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1d56eba9775f050a606d03b6cb3709a8a86adc432542f5218484edc9e3b5136c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006573","is_excluded":false,"label":"Acute hepatic steatosis","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"36c22188e791719c80421b7d9c8db2fa80f8973bc925adf5e95341165c47fd70","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100514","is_excluded":false,"label":"Abnormal circulating vitamin E concentration","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a5a3dc4d18898cc494673080e78a1130551e75908a397c8a6497a646473a58a","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011980","is_excluded":false,"label":"Cholesterol gallstones","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"40c0db33c3dd87398f8da8dde9db63abf0088855cc3ee917afb6c675adcf83c5","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001396","is_excluded":false,"label":"Cholestasis","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"53a3fe6e84c5fc415606abc4c71e7cb6236b2026fa4fdd58328c7b52c50a0c30","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001403","is_excluded":false,"label":"Macrovesicular hepatic steatosis","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"543ced4a37e1225c141d9b3715f4223dbe4e8b438df2e75fd609de8f284315bf","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a7dfb37196efede66dcb87d89925c0127664e3046cf9603f229fe8b512ddeb5c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012397","is_excluded":false,"label":"Aortic atherosclerotic lesion","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a903d9b5336f90504f088eaa099b022bc84fe683b3c0fe103aa6a80950e4fae8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001677","is_excluded":false,"label":"Coronary artery atherosclerosis","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ab6c9e0be4609be55a122d277733ad78d9bb485fe8b692d25a3f5a2086c7ba59","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004943","is_excluded":false,"label":"Accelerated atherosclerosis","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ac88f4d9a49f356a689c9f54ac9918a426831d4b70db4c37a39375f428fc73d2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008372","is_excluded":false,"label":"Abnormal circulating vitamin A concentration","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c6130016cdcb7a8b235cdb83222ebbf0c0cb00c9a100a8333ffeb417553fe309","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003141","is_excluded":false,"label":"Elevated circulating LDL-C concentration","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dffd2d5abe8e79245b3ec5967eb584467f422dab88caa9992d7bbd60691b75cb","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001513","is_excluded":false,"label":"Obesity","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f316e4f3c7f450d5aa993391ac61509f55952018ab8488a82b392a6de743b04a","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012115","is_excluded":false,"label":"Hepatitis","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f404ca633a8e7ef47a0c98fba57d263d53ec26bca73df9a1556faf225ec71f87","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:209902","disease_name":"Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:209902","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/20441\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:209902</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare sterol metabolism disorder characterized by increased LDL cholesterol serum levels (which are resistant to treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors), hypertriglyceridemia, and decreased rate of bile acid excretion, resulting from cholesterol 7alpha-hydroxylase deficiency. Premature gallstone disease and/or premature coronary and peripheral vascular disease are frequently associated.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/20441\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hypercholesterolemia-due-to-cholesterol-7alpha-hydroxylase-deficiency","sourceDocuments":[{"name":"GARD: Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency","reviewed":null,"source_release":"2026-10-21T17:03:34Z","url":"https://rarediseases.info.nih.gov/diseases/20441"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency"},"schemaVersion":1}
